Baird Medical Investment Holdings (BDMD) Current Deferred Revenue (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has 3 years of Current Deferred Revenue data on file, last reported at $200000.0 in Q4 2025.

• On a quarterly basis, Current Deferred Revenue fell 74.75% year-over-year to $200000.0 in Q4 2025; TTM through Dec 2025 was $200000.0, a 74.75% decrease from a year earlier, with the FY2025 full-year figure at $200000.0, down 74.75% from the prior year.
• Current Deferred Revenue for Q4 2025 stood at $200000.0, down from $1.1 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for BDMD reached as high as $1.1 million in Q2 2025 and fell as low as $200000.0 in Q4 2023.
• Historically, Current Deferred Revenue has averaged $571384.0 across 3 years, with a median of $496051.0 in 2023.
• Across the five-year window, Current Deferred Revenue soared 296.05% in 2024 and tumbled 74.75% in 2025, its largest moves.
• Year by year, Current Deferred Revenue stood at $200000.0 in 2023, then surged by 296.05% to $792102.0 in 2024, then tumbled by 74.75% to $200000.0 in 2025.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $200000.0 in Q4 2025, $1.1 million in Q2 2025, and $792102.0 in Q4 2024.